Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Autor: Metts JL; Sarcoma Department, Moffitt Cancer Center, Tampa, Florida, USA.; Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida, USA., Aye JM; Division of Pediatric Hematology-Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA., Crane JN; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Pediatrics, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Oberoi S; Department of Pediatric Hematology/Oncology, Cancer Care Manitoba, Winnipeg, Manitoba, Canada.; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada., Balis FM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Bhatia S; Institute for Cancer Outcomes and Survivorship, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Bona K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Carleton B; Division of Translational Therapeutics, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Dasgupta R; Division of Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA., Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Greenzang KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Kaufman JL; Department of Hematology and Medical Oncology, Emory University, Atlanta, Georgia, USA.; Patient Advocacy Committee, Children's Oncology Group, Monrovia, California, USA., Linardic CM; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, North Carolina, USA., Parsons SK; Institute for Clinical Research and Health Policy Studies and Division of Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts, USA., Robertson-Tessi M; Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Rudzinski ER; Department of Laboratory Medicine and Pathology, Seattle Children's Hospital and University of Washington Medical Center, Seattle, Washington, USA., Soragni A; Department of Orthopedic Surgery, University of California Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA., Stewart E; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee, USA., Weigel BJ; Division of Pediatric Hematology Oncology, University of Minnesota, Minneapolis, Minnesota, USA., Wolden SL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Weiss AR; Department of Pediatrics, Maine Medical Center, Portland, Maine, USA., Venkatramani R; Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Heske CM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

Publikováno v: Cancer [Cancer] 2024 Nov 15; Vol. 130 (22), pp. 3785-3796. Date of Electronic Publication: 2024 Jun 28.

Poverty, race, ethnicity, and survival in pediatric nonmetastatic osteosarcoma: a Children's Oncology Group report.

Autor: Ilcisin L; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Han R; Children's Oncology Group, Monrovia, CA, USA., Krailo M; Children's Oncology Group, Arcadia, CA, USA.; Department of Population and Public Health Sciences Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Shulman DS; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Weil BR; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Weldon CB; Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA., Umaretiya P; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA., Aziz-Bose R; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Greenzang KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Gorlick R; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reed DR; Division of Pediatric Solid Tumors, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Randall RL; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, USA., Nadel H; Division of Radiology, Lucille Packard Children's Hospital at Stanford University, Stanford, CA, USA., Binitie O; Department of Surgery, Moffitt Cancer Center, Tampa, FL, USA., Dubois SG; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Janeway KA; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA., Bona K; Department of Pediatric Oncology, Division of Population Sciences, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Oct 01; Vol. 116 (10), pp. 1664-1674.

Principles in the Development of Contemporary Treatment of Childhood Malignancies: The First 75 Years.

Autor: Greenzang KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Pediatric Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, Massachusetts 02115, USA katie_greenzang@dfci.harvard.edu., Sallan SE; Department of Pediatric Oncology, Dana-Farber Cancer Institute; Division of Pediatric Hematology/Oncology, Boston Children's Hospital; Harvard Medical School, Boston, Massachusetts 02115, USA.

Publikováno v: Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.

Patient-Reported Outcomes in Pediatric Patients With Cancer.

Autor: Reeve BB; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC., Greenzang KA; Department of Pediatric Oncology and Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA., Sung L; Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.

Publikováno v: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2023 May; Vol. 43, pp. e390272.

The predictive trifecta? Fatigue, pain, and anxiety severity forecast the suffering profile of children with cancer.

Autor: Weaver MS; Department of Pediatrics, University of Nebraska, Nebraska Medicine, Omaha, NE, 68198-2155, USA. meweaver@childrensomaha.org.; National Center for Ethics in Healthcare, Washington, DC, USA. meweaver@childrensomaha.org., Wang J; Department of Pediatrics, The George Washington University, Washington, DC, USA.; Division of Biostatistics and Study Methodology, Children's National Hospital, Washington, DC, USA., Greenzang KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA., McFatrich M; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA., Hinds PS; Department of Pediatrics, The George Washington University, Washington, DC, USA.; Department of Nursing Science, Professional Practice and Quality, Children's National Hospital, Washington, DC, USA.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Mar; Vol. 30 (3), pp. 2081-2089. Date of Electronic Publication: 2021 Oct 18.